Contact

The world is in midst of the COVID-19 pandemic.The SARS-CoV-2 lineage B.1.1.28 has been evolving in Brazil since February 2020. A new lineage, named P.1 (B.1.1.28.1), contains convergent mutations in the spike (S) protein, including several receptor binding domain (spike RBD) mutations E484K, K417T, and N501Y.

Spike Mutation in SARS-COV-2 (2019nCOV)
Brazilian variant P.1 lineage (B.1.1.28.1)
Spike-S1 Subunit
N Terminal
L18F
T20N
P26S
D138Y
R190S
Spike-S1-RBD K417N Important residues mutation
E484K
N501Y
Spike-S1 Subunit C Terminal D614G A popular mutation in different new SARS-CoV-2 lineage
H655Y
Spike-S2 Subunit T1027I
V1176F

GeneMedi pseudotype virus (pseudovirus) of SARS-COV-2 (2019nCOV) P.1 lineage (B.1.1.28.1, Brazilian variant)


SARS-COV-2 (2019nCOV)-P.1 lineage(B.1.1.28.1, Brazilian variant) of Spike protein & ACE2 competition binding assay for efficacy evaluation of COVID-19 vaccines and therapeutic antibodiess

GeneMedi codon-optimized spike mammalian expression vector for SARS-COV-2 (2019nCOV) - P.1 lineage(B.1.1.28.1, Brazilian variant)




GENEMEDI
6th Floor, Buiding No.2, Kangxin Road 3377, Shanghai, China
Email: [email protected] [email protected]
Telephone: +86-21-50478399   Fax: 86-21-50478399
Privacy Policy
Chinese Website

COVID-19
related
protocols,
data and
products

COVID-19 related protocols, data and products

×